南方财经1月23日电，宝色股份(300402.SZ)发布公告称，股东山西华鑫海贸易有限公司于2026年1月19 日至2026年1月21日期间通过集中竞价方式减持公司股份。此次减持共涉及2,460,000股，占公司总股本 的0.9968%，减持均价为22.63元/股，对应金额约5567万元。减持后，山西华鑫海持有宝色股份 13,320,000股，持股比例由6.3941%下降至5.3973%。 ...

相关上市企业：天工股份（920068）、金天钛业（688750）、宝钛股份（600456）、西部超导 （688122）、西部材料（002149）、惠云钛业（300891）、钒钛股份（000629）、宝色股份（300402） 等。 相关企业：宝鸡鑫诺特材股份有限公司、宝鸡好得钛业股份有限公司、州博康特材科技有限公司、西安 中钛金属有限公司等。 关键词：医用钛合金行业发展历程、医用钛合金行业市场规模、医用钛合金行业竞争格局、医用钛合金 行业发展趋势 一、医用钛合金行业相关概述 医用钛合金是一类专用于制造人体植入物的生物医用金属材料，其核心特性包括优良的生物相容性、高 比强度（可达300MPa·cm³/g以上）、适中的弹性模量（约110GPa，接近人骨的10-30GPa），以及表面 形成的二氧化钛钝化膜带来的优异耐腐蚀性。这使得医用钛合金在骨科植入物、心血管器械以及口腔修 复领域得到广泛应用。 医用钛合金优势 内容概要：医用钛合金作为一种新型合金，同时也是一种载体材料，被广泛应用于肢体植入、替代性功 能材料、牙科、医疗器械等相关领域。近年来，随着我国人口老龄化趋势的加剧，慢性疾病的发病率也 在增加，这将导致对医疗器 ...

证券代码：300402 证券简称：宝色股份 公告编号：2026-001 南京宝色股份公司 | 基本情况 1. | | | | --- | --- | --- | | | 信息披露义务人 | 山西华鑫海贸易有限公司 | | | 住所 | 山西综改示范区太原学府园区龙兴街192号1幢4层403室 | | | 权益变动时间 | 2026年1月19日至2026年1月21日 | | | 权益变动过程 | 山西华鑫海因资金需求于2026 年 1月 19 日至 2026 年 1 月 | | | 21 | 日期间，通过深圳证券交易所交易系统以集中竞价方式累计减持公 | 一、股东减持股份触及 1%整数倍的情况 1 | | 司股份2,460,000股，占公司总股本的0.9968%。本次减持后，山西华 | | | | | --- | --- | --- | --- | --- | | | 鑫海持有本公司的股份由15,780,000股减少至13,320,000股，占公司 | | | | | | 总股本的比例由6.3941%减少至5.3973%，减持股份比例触及1%的整 | | | | | 数倍。 | | | | | | | 截至本公 ...

（文章来源：证券日报） 证券日报网讯 1月21日，宝色股份在互动平台回答投资者提问时表示，截至2026年1月20日，公司股东 人数为28238户。 ...

Core Viewpoint - Baose Co., Ltd. focuses on the research, design, manufacturing, and sales of special materials non-standard pressure vessel equipment, primarily involving titanium, zirconium, nickel, and high-grade stainless steel, with applications across various industries [1] Company Overview - The company specializes in non-standard pressure vessel equipment made from special materials, including heat exchangers, towers, reactors, and pipeline fittings [1] - Its products are widely used in chemical, energy, metallurgy, electric power, environmental protection, shipbuilding, and marine engineering sectors [1] Industry Context - The company is positioned as a professional supplier in the domestic special materials non-standard equipment manufacturing field [1] - With the ongoing transformation of the national energy industry and the deepening of the "dual carbon" strategy, the company aims to expand into new business areas [1] - The continuous expansion of downstream application fields for special materials non-standard pressure vessel equipment is expected to drive the company's growth towards new productive forces [1]

Group 1: Company Announcements - Zhongwei Company plans to acquire 64.69% equity of Hangzhou Zhonggui through a combination of share issuance and cash payment, aiming to enhance its capabilities in CMP equipment and solutions [1] - Lixun Precision intends to repurchase shares worth between 1 billion to 2 billion RMB for employee stock ownership plans or equity incentives, with a maximum repurchase price of 86.96 RMB per share [2] - ZaiJing Pharmaceutical has reached a global strategic cooperation and licensing agreement with AbbVie for the development and commercialization of ZG006, receiving an upfront payment of 100 million USD [3] - Tianci Materials expects a net profit increase of 127% to 231% for 2025, driven by significant growth in lithium-ion battery material sales [4] - Meike Home plans to acquire 100% equity of Shenzhen Wande Technology through share issuance and cash payment, with stock resuming trading on January 5, 2026 [6][7] - ST KeliDa is planning a change in control, with stock suspension starting January 5, 2026, due to the transfer of 100% equity of its controlling shareholder [8] - Xinzhou Bang intends to invest approximately 260 million USD in a lithium-ion battery materials project in Saudi Arabia, enhancing its global capacity and supply chain [9] Group 2: Financial Performance - Kid's King anticipates a net profit increase of 51.72% to 82.06% for 2025 [9] - Guangku Technology expects a net profit growth of 152% to 172% for 2025 [9] Group 3: Mergers and Acquisitions - Xidi Micro plans to acquire 100% equity of Chengxin Micro for 310 million RMB [9] - Haili Biological's subsidiary intends to acquire 51% equity of seven dental chain companies for 61.2 million RMB [9]

Core Viewpoint - The company Baose Co., Ltd. has successfully won a public tender for the procurement of a complete set of multi-crystalline silicon reactor equipment for the second phase of the 700-ton ultra-pure multi-crystalline silicon project from Shaanxi Youse Tianhong Ruike Silicon Materials Co., Ltd. [1] Group 1 - The winning bid amount for the project is RMB 273.1 million [1] - A procurement contract has been signed between the company and Tianrui Company [1] - Tianrui Company is considered a related party due to its controlling shareholder being a wholly-owned subsidiary of the company's actual controller, Shaanxi Youse Metal Holding Group Co., Ltd. [1]

Core Viewpoint - Baose Co., Ltd. has successfully won a bid for the procurement project of a complete set of multi-crystalline silicon reactors for the second phase of the 700-ton ultra-pure multi-crystalline silicon project from Shaanxi Youse Tianhong Ruike Silicon Materials Co., Ltd. with a bid amount of 273 million yuan [1] Group 1 - The project bid amount is 273 million yuan [1] - The procurement contract has been signed between Baose Co., Ltd. and Tianhong Ruike [1] - Both companies are under the control of the same parent company, Shaanxi Youse Group, indicating that this transaction is a related party transaction [1]

Core Viewpoint - The company Baose Co., Ltd. has successfully won a public tender for the procurement of a complete set of multi-crystalline silicon reactor equipment for the second phase of the 700-ton ultra-pure multi-crystalline silicon project from Shaanxi Youse Tianhong Ruike Silicon Materials Co., Ltd. [1] Group 1 - The winning bid amount for the project is RMB 273.1 million [1] - A procurement contract has been signed between the company and Tianhong Ruike [1] - The controlling shareholder of Tianhong Ruike, Shaanxi Youse Tianhong New Energy Co., Ltd., holds 81.3107% of the shares and is a wholly-owned subsidiary of Shaanxi Youse Metal Holding Group Co., Ltd., which is the actual controller of the company [1] Group 2 - The transaction constitutes a related party transaction as both the company and Tianhong Ruike are controlled by the same entity, Shaanxi Youse Group, according to the relevant regulations of the Shenzhen Stock Exchange [1]

证券代码：300402 证券简称：宝色股份 公告编号：2025-072 南京宝色股份公司 关于签署中标项目合同暨关联交易的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、关联交易基本概述 南京宝色股份公司（以下简称"公司"）于近日参与了陕西有色天宏瑞科硅材 料有限责任公司（以下简称"天瑞公司"）"700 吨超纯多晶硅项目二阶段多晶硅 反应器成套装置采购项目"的公开招标，并成功中标。该项目中标金额为人民币 27,310 万元。公司与天瑞公司签署了该中标项目的采购合同。 由于天瑞公司的控股股东陕西有色天宏新能源有限责任公司（其持有天瑞公司 81.3107%的股权，以下简称"新能源公司"）为本公司实际控制人陕西有色金属控 股集团有限责任公司（以下简称"陕西有色集团"）的全资子公司，因此，本公司 与天瑞公司受同一控制人陕西有色集团控制，根据《深圳证券交易所创业板股票上 市规则》的相关规定，天瑞公司为公司的关联法人，本次交易构成关联交易。 2025 年 12 月 31 日，公司第六届董事会第十七次会议审议通过了《关于公司签 署中标项目合同暨关联交易的议案》，关 ...